Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitlePhase Ib Trial of the PI3K Inhibitor Copanlisib Combined with the Allosteric MEK Inhibitor Refametinib in Patients with Advanced Cancer.AuthorsRamanathan, Ramesh K.; Von Hoff, Daniel D.; Eskens, Ferry; Blumenschein, George; Richards, Donald; Genvresse, Isabelle; Reschke, Susanne; Granvil, Camille; Skubala, Adam; Peña, Carol; Mross, Klaus; Blumenschein, George JrPublicationTargeted Oncology, 2020, Vol 15, Issue 2, p163ISSN1776-2596Publication typejournal articleDOI10.1007/s11523-020-00714-0